Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,756 | -17,170 | -10,688 | -4,998 | -20,795 |
| Depreciation Amortization | 1,266 | 960 | 639 | 308 | 1,220 |
| Accounts receivable | 765 | 764 | -5 | 753 | -572 |
| Accounts payable and accrued liabilities | 1,385 | 973 | -33 | 10 | -19 |
| Other Working Capital | 1,839 | 1,761 | 999 | 922 | -638 |
| Other Operating Activity | 300 | 196 | 903 | -720 | 2,855 |
| Operating Cash Flow | $-18,201 | $-12,516 | $-8,185 | $-3,725 | $-17,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -179 | -7 | -7 | -6 | -980 |
| Investing Cash Flow | $-179 | $-7 | $-7 | $-6 | $-980 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | 4,767 | 20,000 |
| Debt Repayment | N/A | -636 | N/A | N/A | N/A |
| Common Stock Issued | 10,209 | 3,149 | 281 | 0 | 3,561 |
| Dividend Paid | -1,819 | -1,820 | -1,820 | -1,213 | -2,447 |
| Other Financing Activity | -1,757 | -100 | -469 | 0 | -916 |
| Financing Cash Flow | $16,633 | $10,593 | $7,992 | $3,554 | $20,198 |
| Exchange Rate Effect | 3 | 3 | 4 | 6 | -5 |
| Beginning Cash Position | 5,483 | 5,483 | 5,483 | 5,483 | 4,219 |
| End Cash Position | 3,739 | 3,556 | 5,287 | 5,312 | 5,483 |
| Net Cash Flow | $-1,744 | $-1,927 | $-196 | $-171 | $1,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,201 | -12,516 | -8,185 | -3,725 | -17,949 |
| Capital Expenditure | -179 | -7 | -7 | -6 | -980 |
| Free Cash Flow | -18,380 | -12,523 | -8,192 | -3,731 | -18,929 |